The entire protocol can delivered virtually after the initial audiogram and physical assesment.
Free training included
Neuromonics provides clinical training free of charge — including for additional clinicians at your existing practice. You get access to the provider portal, patient management tools, clinical support from Neuromonics specialists, and all the resources you need to start delivering successful outcomes immediately.
Add a Clinically-Validated Tinnitus Treatment to Your Practice
Your patients with tinnitus need more than a referral elsewhere. Neuromonics gives your practice a complete, evidence-backed tinnitus treatment solution delivered through an app your patients use at home, monitored through your provider portal, and backed by 20 years of peer-reviewed clinical evidence. No additional equipment. No lengthy in-clinic sessions. A new revenue stream and a new reason for patients to stay loyal to your practice.
How Neuromonics Complements — Not Competes With — Your Hearing Aid Practice
We understand the concern. Hearing aids are a significant revenue driver for most audiology practices, and any new treatment program needs to make business sense. Here is the reality: tinnitus and hearing loss coexist in approximately 80% of cases. Hearing aids address the hearing loss. Neuromonics addresses the tinnitus. They are complementary, not competing. Offering both means your tinnitus patients stay in your practice rather than being referred elsewhere, your hearing aid patients get a complete tinnitus solution alongside their amplification, and you generate additional revenue from tinnitus treatment without reducing hearing aid sales.
The clinical case for combining both
Multiple clinical studies show that patients who use hearing aids combined with Neuromonics sound therapy achieve better tinnitus outcomes than either treatment alone. For patients with co-occurring hearing loss and tinnitus, prescribing both is the clinically optimal approach — and the strongest business case for your practice.
Clinical Evidence Your Patients Will Trust
When a patient asks why they should trust this treatment, you need an answer backed by evidence — not just a brochure. Neuromonics has the most extensive clinical evidence base of any tinnitus treatment currently available: 10 peer-reviewed studies, 1,033+ patients, 83% average success rate — defined as a 40% or greater reduction in Tinnitus Reaction Questionnaire (TRQ) score. Seven of those studies were conducted by independent researchers. You can refer patients with confidence.
We deliver the platform. You deliver the care.
1
Remote care flexibility
Your patients complete treatment at home using the Neuromonics app on their phone. You monitor their progress, compliance, and outcomes through the provider portal without requiring additional appointments. Extend your tinnitus care beyond the clinic walls.
2
Audiogram-personalized treatment
The Neuromonics algorithm personalizes the acoustic stimulation to each patient's specific hearing profile — the same profile you already have from their audiogram. No additional testing required. Upload their audiogram and the app does the rest.
3
Analytics dashboard
Track every patient's usage, compliance, and self-reported outcomes in real time. See which patients are engaging consistently and which need a check-in. Generate outcome reports for insurance documentation or referral letters.
4
Treatment controls
Adjust treatment parameters for individual patients through the provider portal. Advance patients through treatment phases, modify acoustic settings, and personalize the program without the patient needing to come in.
5
Ongoing clinical support
Access Neuromonics clinical training, patient education materials, and a dedicated support team. We provide everything you need to confidently offer tinnitus treatment — including patient handouts, consultation frameworks, and clinical protocols.
83%
Average success rate
Across 10 clinical studies
1,033+
Patients studied
US & Australian medical centers
96%
Highest single-study result
Hollywood VA (Veterans Affairs)
Study
Subjects
Location
Type
Success*
Hollywood VA
35
Veterans Affairs US
Independent
96%
Private Practice
470
Australia
Neuromonics
92%
T2 – NTT vs SOC
50
Australia
Neuromonics
90%
Tavori TRI
25
Australia
Independent
90%
T3 – Phase 1 vs 2
35
Australia
Neuromonics
86%
CALM Study
51
United States
Independent
81%
Lions Ear Institute
29
Australia
Independent
75%
Tavora AAA
70
US / Australia
Independent
75%
Australian Veterans
50
Veterans Affairs AU
Independent
74%
Oregon Tinnitus
24
United States
Independent
72%
Total / Average
1,033
83%
*Success = clinically significant reduction in tinnitus disturbance. 10 studies across US & Australian medical centers, 2007–2010.
🏥
Independent verification
7 of 10 studies conducted by independent researchers — not Neuromonics
👨⚕️
Veterans Affairs validated
96% success at Hollywood VA — among the most rigorous real-world settings
📊
Largest real-world study
470-patient private practice study — 92% success rate
Yes — Neuromonics is a clinician-administered protocol that requires training to deliver correctly. Neuromonics provides training free of charge, including for additional clinicians at existing practices. Once trained, you'll have access to the provider portal, clinical support, and all the tools you need to deliver successful outcomes.
After your initial assessment and fitting, the patient uses the Neuromonics app at home for 2–4 hours daily. The app delivers their personalized acoustic therapy. You monitor their progress, usage data, and clinical measurements through the provider portal. Neuromonics also supports patients through in-app podcasts, a patient handbook, and automated reminders.
Neuromonics requires approximately half the clinic time of TRT, while achieving the same success rate in a third of the therapy time. The combination of personalized acoustic stimulation and in-app patient education handles much of the patient education that would otherwise require clinic time.
91% of patients achieve significant reduction in tinnitus disturbance, 86% achieve significant reduction in tinnitus awareness, and 97% would recommend the treatment. Active treatment typically runs 6–8 months followed by a maintenance phase of 2–4 hours per week.
Yes — hearing aids and Neuromonics are complementary. Patients use hearing aids for communication and Neuromonics during quieter periods when tinnitus is most bothersome. For patients with co-occurring hearing loss and tinnitus, prescribing both produces the strongest outcomes.
No. Tinnitus and hearing loss coexist in approximately 80% of cases but require different treatments. Hearing aids address hearing loss. Neuromonics addresses tinnitus. Offering both keeps tinnitus patients in your practice and generates additional treatment revenue alongside your existing hearing aid business.
Registered providers have access to Neuromonics Clinical Specialists for any patient issues — including complex cases, protocol modifications, and troubleshooting. Our team is here to support your patients' outcomes as much as you are.
Ready to offer your patients a tinnitus solution?
Join the audiologists and hearing care professionals who use Neuromonics every day. Platform access, clinical training, and patient support included.
Our proprietary algorithms modify music to account for individual hearing profiles, providing targeted stimulation to the auditory system that promotes neurological desensitization to tinnitus.
Our proprietary algorithms modify music to account for individual hearing profiles, providing targeted stimulation to the auditory system that promotes neurological desensitization to tinnitus.
Our proprietary algorithms modify music to account for individual hearing profiles, providing targeted stimulation to the auditory system that promotes neurological desensitization to tinnitus.
